Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

This study has been terminated.
(lack of accrual)
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT00709397
First received: July 1, 2008
Last updated: July 29, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)